More on CLDX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $41.79 |
|
|||
| Open | $42.10 | ||||
| 52 Wk High | $18.62 | ||||
| 52 Wk Low | $2.85 | ||||
| Day High | $43.20 | ||||
| Day Low | $41.33 | ||||
| P/E | N/A | ||||
| EPS | $-1.02 | ||||
| Volume | 772,645 | ||||
- Form SCHEDULE 13G/A Celldex Therapeutics, Filed by: Kynam Capital Management, LP
- Form SCHEDULE 13G Celldex Therapeutics, Filed by: PRICE T ROWE ASSOCIATES INC /MD/
- Celldex Therapeutics (CLDX) PT Raised to $53 at Barclays
- Form 10-Q Celldex Therapeutics, For: Jun 30
- Celldex (CLDX) Tops Q2 EPS by 12c
- Form 8-K Celldex Therapeutics, For: Aug 06
- Celldex Reports Second Quarter Financial Results and Provides Corporate Update
- Celldex Therapeutics (CLDX) PT Raised to $72 at Wells Fargo
- Celldex Therapeutics (CLDX) PT Lowered to $40 at Morgan Stanley
- Celldex Therapeutics (CLDX) PT Lowered to $61 at Cantor Fitzgerald
Entities mentioned with CLDX
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- 13G | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- S3 | View Related Stories »
- Cantor Fitzgerald | View Related Stories »
- Show More...
